Wasley, A., S. Grytdal, and K. Gallagher. 2008. Surveillance for acute viral hepatitis—United States, 2006. Morbidity and Mortality Weekly Report: Surveillance Summaries 57(2):1-24.

Weinbaum, C., R. Lyerla, and H. S. Margolis. 2003. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. Morbidity and Morality Weekly: Recommendations and Reports 52(RR-1):1-36; quiz CE31-CE34.

Weinbaum, C. M., I. Williams, E. E. Mast, S. A. Wang, L. Finelli, A. Wasley, S. M. Neitzel, and J. W. Ward. 2008. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Morbidity and Morality Weekly: Recommendations and Reports 57(RR-8):1-20.

Weiss, R. A., and A. J. McMichael. 2004. Social and environmental risk factors in the emergence of infectious diseases. Nature Medicine 10(12 Suppl):S70-S76.

WHO (World Health Organization). 2001. Introduction of hepatitis B vaccine into childhood immunization services: Management guidelines, including information for health workers and parents. Geneva: World Health Organization.

———. 2009. Hepatitis B fact sheet no. 204. http://www.who.int/mediacentre/factsheets/fs204/en/ (accessed October 20, 2008).

Wise, M., S. Bialek, L. Finelli, B. P. Bell, and F. Sorvillo. 2008. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 47(4):1128-1135.

Wong, J., G. McQuillan, J. McHutchison, and T. Poynard. 2000. Estimating future hepatitis C morbidity, mortality, and costs in the United States. American Journal of Public Health 90(10):1562-1569.

Xia, X., J. Luo, J. Bai, and R. Yu. 2008. Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis. Public Health 122(10):990-1003.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement